This content is machine translated HSP90 inhibition A new therapeutic approach for breast cancer In an initial phase II study in metastatic breast cancer, the HSP90 inhibitor ganetespib has shown promising antitumor activity in HER2-positive and triple-negative breast cancer (TNBC). Due to the favorable…
View Post 3 min This content is machine translated 2nd EORTC St. Gallen Gastrointestinal Cancer Conference 2014 VEGF inhibition in metastatic colorectal cancer. The use of the VEGF inhibitor bevacizumab improves the outcome of patients with metastatic colorectal cancer regardless of the chemotherapy chosen. Recent data suggest that the duration of VEGF inhibition…
View Post 2 min This content is machine translated Skin cancer Do we need to rethink our lifestyle in the fight against skin cancer? The topic could hardly be more explosive: Already about half of the over 60-year-olds suffer from actinic tumors. In Switzerland, we are also European champions in terms of melanoma incidence.…
View Post 7 min This content is machine translated Pediatric hematology and oncology Acute childhood leukemias: an update. A child with unexplained cytopenia and additional symptoms such as fever, lymphadenopathy, or hepatosplenomegaly should be generously and rapidly referred to a center. Hyperleukocytosis, tumor lysis syndrome, and mediastinal tumor…
View Post 3 min This content is machine translated News on melanoma therapy at ASCO 2014 How do immunotherapies work in combination and in the adjuvant setting? In the course of this year’s ASCO congress in Chicago at the beginning of June, new results of the phase Ib study on the combination of PD1 and CTLA4 inhibition…
View Post 2 min This content is machine translated Pediatric and geriatric oncology Treat young and old correctly This issue of InFo ONKOLOGIE & HÄMATOLOGIE is about tumors in pediatrics and geriatrics.
This content is machine translated Brain tumor New surgical method brings important breakthrough Surgical injuries to the motor center in the brain and its pathways have severe consequences, e.g. paralysis of the arm or leg. Not least because of this, tumors in these…
View Post 2 min This content is machine translated SAKK publication Cancer patients receive different regional treatment at the end of their lives A study co-led by the Swiss Association for Clinical Cancer Research (SAKK) and published in the journal BMC Cancer concludes that place of residence, insurance, age, and type of cancer…
View Post 12 min This content is machine translated Neuroendocrine tumors Not as rare as you might think Neuroendocrine tumors (NET) are not that rare. The prevalence of these tumors in the gastrointestinal tract is exceeded only by colon carcinoma. Often NETs are not detected until the late…
View Post 3 min This content is machine translated Care situation for rare diseases Many affected people are still in childhood How are rare diseases defined in the first place and what is the epidemiological situation in Switzerland? In principle, a condition is considered rare or neglected if no more than…
View Post 5 min This content is machine translated Second St. Gallen EORTC Conference Multimodality treatment of advanced rectal cancer. Which drugs are suitable for neoadjuvant radiochemotherapy? If there is a complete clinical response, should we wait or operate? And which patients benefit from adjuvant treatment? These were some of…
